Director Sells 33,000 Impinj: Insider Move to Watch
A high-profile insider move hits Impinj as a director sells 33,000 impinj shares. Learn what this signals, how to ana...
What Features To Look For In No Annual Fee Cards
Understanding the key features of no annual fee cards can help you maximize benefits. Discover what to prioritize for your financial needs.
18,760 articlesSepterna's Chief People Officer Stock Move: Investor View
A senior insider at Septerna sold nearly 12,000 shares in a single move, raising questions for investors. This articl...
Spacex Stock Down From High After Nasdaq-100: Is It a Buy?
SpaceX joined the Nasdaq-100 with high expectations, but the first day brought a meaningful pullback. This guide brea...
York Just Banned Data: What It Means for Microsoft, Amazon, and Google
New York’s decision to pause large-scale data center projects up to a year changes the playing field for cloud giants...
What This MannKind Director Signals Risk to Royalties
A single director's sale at MannKind raises questions about the durability of royalty streams. This analysis breaks d...
Coeur Mining (CDE) 2025 Earnings Outlook and Q4 Review
Investors are weighing how Coeur Mining performed in Q4 2025 and what it means for coeur mining (cde) 2025. This view...
Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
KBR (KBR) 2025 Earnings Call: Key Takeaways for Investors
As KBR prepares to unveil its Q4 2025 results, investors should focus on backlog, margins, and free cash flow. This g...
Chart Industries Just Delivered Big EBITDA—Why Sell?
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
Why Shares Walmart Sinking Today: What Investors Should Do
When a blue-chip stock slips, it can be more noise than signal. This article dives into why shares walmart sinking to...
Paramount Beat Netflix Battle: Who Really Won the War
When Paramount beat Netflix in the bid for Warner Bros. Discovery’s assets, headlines screamed victory. This piece di...
Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status